Skip to main content
. 2021 Aug 8;38(9):4872–4884. doi: 10.1007/s12325-021-01853-0

Fig. 3.

Fig. 3

Indirect comparison of rVIII-SingleChain versus rFVIIIFc for a estimated mean ABR, b percentage of patients with zero bleeds and c mean annualized rFVIII consumption, before and after matching. Estimated by negative binomial regression model. (Total rFVIIIFc IU/kg received during the efficacy period/number of days in efficacy period) × 365.25. P values for comparisons after matching were 0.32 for ABR, 0.35 for percentage of patients with zero bleeds and 0.85 for annualized rFVIII consumption. ABR annualized bleeding rate, CI confidence interval, rFVIII recombinant factor VIII